Full Text View
Tabular View
No Study Results Posted
Related Studies
Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)
This study is ongoing, but not recruiting participants.
Study NCT01578070   Information provided by Viscogel AB

First Received on April 11, 2012.   Last Updated on October 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
0.2μg Act-HIB®
ViscoGel® and 0.2μg Act-HIB®
ViscoGel® and 2μg Act-HIB®
2μg Act-HIB®
10μg Act-HIB®
Sponsors listed in this trial
Viscogel AB
Karolinska Institutet
Pharma Consulting Group AB


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services